References
- Anderson S. J., Gonda M. A., Rettenmier C. W., Sherr C. J. Subcellular localisation of glycoproteins encoded by the viral oncogene v-fms. J. Virol. 1984; 51: 730–741
- Austyn J. M., Gordon S. F4/80, a monoclonal antibody directed specificity against the mouse macrophage. Eur. J. Immunol. 1981; 11: 805–815
- Bhattacharya A., Dorf M. E., Springer T. A. A shared alloantigenic determinant on ia antigens encoded by the I-A and I-E subregions: evidence for 1 region gene duplication. J. Immunol. 1981; 127: 2486–2495
- Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–1237
- Coussens L., Van Beveren C., Smith D., Chen E., Mitchell R. L., Isacke C. M., Verma I. M., Ullrich A. Structural alterations of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 1986; 320: 277–280
- Crocker P. R., Gordon S. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J. Exp. Med. 1989; 169: 1333–1346
- Dean M., Cleveland J. L., Rapp U. R., Ihle J. N. Role of myc in the abrogation of IL-3 dependence of FDC-P1 cells. Oncogene Res. 1987; 1: 279–296
- Dexter T. M., Spooncer E. Growth and differentiation in the hemopoietic system. Annu. Rev. Cell Biol. 1987; 3: 423–441
- Dexter T. M., Garland J., Scott D., Scolnick E., Metcalf D. Growth of factor-dependent hemopoietic precursor cell lines. J. Exp. Med. 1980; 152: 1036–1047
- Dialynas D. P., Wilde D. B., Marrack P., Pierres A., Wall K. A., Havran W., Otten G., Loken M. R., Pierres M., Kappler J., Fitch F. W. Characterization of the murine antigenic determinant, designated L3T4a, recognised by monoclonal antibody GK1.5. Immunol. Rev. 1983; 74: 29–56
- Donner L., Fedele L. A., Garon C. F., Anderson S. J., Sherr C. J. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms). J. Virol. 1982; 41: 489–500
- Furman W. L., Rettenmier C. W., Chen J. H., Roussel M. F., Quinn C. O., Sherr C. J. Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product. Virology 1986; 152: 432–445
- Green S. M., Lowe A. D., Parrington J., Karn J. Transformation of growth factor-dependent myeloid stem cells with retroviral vectors carrying c-myc. Oncogene 1989; 4: 737–751
- Greenberger J. S., Sakakeeny M. A., Humphries R. K., Eaves C. J., Eckner R. J. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) haematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. USA 1983; 80: 2931–2935
- Hapel A. J., Warren H. S., Hume D. A. Different colony-stimulating-factors are detected by ‘interleukin-3′-dependent cell lines. FDC-P1 and 32D cl-23. Blood 1984; 64: 786–790
- Hariharan I. K., Adams J. M., Cory S. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 1988; 3: 387–399
- Holden H. T., Lichter W., Siegel M. N. Quantitative methods for measuring cell growth and death. Tissue Culture, Methods and Applications, P. F. Kruse, M. K. Patterson. Academic Press. 1973; 408–412
- Karn J., Watson J. V., Lowe A. D., Green S. M., Vedeckis W. Regulation of cell cycle duration by c-myc levels. Oncogene 1989; 4: 773–878
- Kawasaki E. S., Ladner M. B., Wang A. M., Arsdell J. V., Warren M. K., Coyne M. Y., Schweickart V. L., Lee M.-T., Wilson K. J., Boosman A., Stanley E. R., Ralph P., Mark D. F. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985; 230: 291–296
- Koch G., Smith M., Macer D., Webster P., Mortara R. Endoplasmic reticulum contains a common, abundant calcium-binding glycoprotein, endoplasmin. J. Cell Sci. 1986; 86: 217–232
- Lyman S. D., Park L., Rohrschneider L. R. Colony stimulating-factor-1 induced growth stimulation of v-fms transformed fibroblasts. Oncogene 1988; 3: 391–395
- Mann R., Mulligan R. C., Baltimore D. B. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153–159
- McDonough S. K., Larsen S., Brodey R. S., Stock N. D., Hardy W. D., Jr. A transmissible feline fibrosarcoma of viral origin. Cancer Res. 1971; 31: 953–956
- Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16–22
- Metcalf D., Roberts T. M., Cherington V., Dunn A. R. The in vitro behaviour of hemopoietic cells transformed by polyoma middle T antigen parallels that of primary human myeloid leukemic cells. 1987
- Miller A. D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol. 1986; 6: 2895–2902
- Morrison D. K., Browning P. J., White M. F., Roberts T. M. Tyrosine phosphorylations in vivo associated with v-fms transformation. Mol. Cell Biol. 1988; 8: 176–185
- Nicola N. A. Why do hemopoietic growth factor receptors interact with each other?. Immunol. Today 1987; 8: 134–139
- Pierce J. H., Ruggiero M., Fleming T. P., Di Flore P. P., Greenberger J. S., Varticouski L., Schlessinger J., Rovera G., Aaronson S. A. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science 1988; 2: 628–630
- Rosen H., Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 1987; 81: 115–129
- Rothwell V. M., Rohrschneider L. R. Murine c-fms cDNA: cloning, sequence analysis and retroviral expression. Oncogene Res. 1987; 1: 311–324
- Roussel M. F., Rettenmier C. W., Look A. T., Sherr C. J. Cell surface expression of v-fms-coded glycoprotein is required for transformation. Mol. Cell Biol. 1984; 4: 1999–2009
- Roussel M. F., Dull T. J., Rettenmier C. W., Ralph P., Ullrich A., Sherr C. J. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 1987; 325: 549–552
- Roussel M. F., Downing J. R., Rettenmier C. W., Sherr C. J. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 1988; 55: 979–988
- von Ruden T., Wagner E. F. Expression of functional human EGF receptor on murine bone marrow cells. EMBO J. 1988; 7: 2794–2756
- Sacca R., Stanley E. R., Sherr C. J., Rettenmier C. W. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. Proc. Natl. Acad. Sci. USA 1986; 83: 3331–3335
- Sherr C. J., Rettenmier C. W., Sacca R., Roussel M. F., Look A. T., Stanley E. R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665–676
- Springer T. A. Monoclonal antibody analysis of complex biological systems. J. Biol. Chem. 1981; 256: 3833–3839
- Springer T. A., Galfre G., Secher D. S., Milstein C. Mac-1: a macrophage differentiation antigen identified by a monoclonal antibody. Eur. J. Immunol. 1979; 9: 301–306
- Steinman R. M., Nogueira N., Witmer M. D., Tydings J. D., Mellman I. S. Lymphokine enhances the expression and synthesis of la antigens on cultured mouse peritoneal macrophages. 1980
- Wheeler E. F., Rettenmier C. W., Look A. T., Sherr C. J. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line. Nature 1986; 324: 377–380
- Wheeler E. F., Askew D., May S., Ihle J. N., Sherr C. J. The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1. Mol. Cell Biol. 1987; 7: 1673–1680
- Whetton A. D., Dexter T. M. Haemopoietic growth factors. TIBS 1986; 11: 207–211
- Whetton A. D., Bazill G. W., Dexter T. M. Haemopoietic growth factor mediates cell survival via its action on glucose transport. EMBO J. 1984; 3: 409–413
- Whetton A. D., Monk P. N., Consalvey S. D., Huang S. J., Dexter T. M., Downes C. P. Interleukin-3 stimulates proliferation via protein kinase C activation without increasing inositol lipid turnover. Proc. Natl. Acad. Sci. USA 1988; 85: 3284–3288
- Woolford J., McAuliffe A., Rohrscheider L. R. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 1988; 55: 965–977